MAPK3 and familial pancreatic carcinoma: Leukotriene B4 (LTB4) is a downstream metabolite of 5-LOX and stimulates pancreatic cancer cell growth through ERK1/2 phosphorylation, which can be inhibited by an LTB4 receptor antagonist (Tong et al, 2002).